| View |
|
DRP-244-05
|
Mefenamic Acid
|
Fenady
|
50mg/5mL
|
Suspension
|
Anti-Inflammatory and Antirheumatic (Fenamate)
|
New Myrex Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 December 2022
|
16 November 2027
|
| View |
|
DRP-9201-03
|
Cholecalciferol (Vit.D3)
|
Vitali-D
|
3,000 IU (equivalent to 75 mcg)
|
Capsule
|
-
|
San Marino Laboratories Corporation
|
Philippines
|
-
|
12 October 2021
|
08 October 2025
|
| View |
|
DRP-2571-01
|
Losartan Potassium + Hydrochlorothiazide
|
Losarcure Plus
|
100mg / 25mg
|
Film-Coated Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
13 October 2021
|
05 April 2025
|
| View |
|
DRP-9166-02
|
Clopidogrel (as bisulfate)
|
Cassagrel
|
75mg
|
Film-Coated Tablet
|
-
|
Zim Laboratories Limited
|
India
|
-
|
13 October 2021
|
21 September 2025
|
| View |
|
DRP-6174-06
|
Co-Amoxiclav
|
Clavinyx
|
457 mg per 5 mL
|
Powder For Suspension
|
-
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
-
|
13 October 2021
|
15 December 2024
|
| View |
|
DRP-1431-07
|
Amoxicillin (As Trihydrate)
|
Tgmox
|
500 mg
|
Capsule
|
ANTIBACTERIAL (PENICILLIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 July 2022
|
02 August 2027
|
| View |
|
DRP-7445-01
|
Etoricoxib
|
None
|
60mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Cadila Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
08 November 2022
|
02 November 2027
|
| View |
|
DRP-299-02
|
Dopamine Hydrochloride
|
Doptrex
|
40 mg/mL
|
Solution For Intravenous Infusion
|
Adrenergic Agent
|
Troikaa Pharmaceuticals, Limited
|
India
|
Automatic Renewal
|
10 October 2022
|
28 September 2027
|
| View |
|
DRHR-2062
|
Menthol + Camphor + Eucalyptus Oil
|
Vaporin Aromatherapy Oil - Chamomile
|
437.50 mg/ 43.75 mg/ 43.75 mg per mL
|
Liniment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
-
|
08 October 2021
|
08 October 2026
|
| View |
|
DRP-3322-05
|
Azithromycin (as dihydrate)
|
Rexithro
|
200 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
27 March 2024
|
08 July 2029
|
| View |
|
DRP-10526
|
Ofloxacin
|
Dizoflox
|
3mg/mL (0.3 %)
|
Otic Solution
|
Antibacterial (Quinolone)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
23 February 2024
|
18 February 2029
|
| View |
|
DRP-5518-21
|
Cefixime (as trihydrate)
|
Neocefixim
|
100 mg/ 5 mL
|
Powder For Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
Renewal
|
03 April 2024
|
17 September 2029
|
| View |
|
DRP-8929-07
|
Norepinephrine (As Bitartrate)
|
Noreson
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (1.V.)
|
-
|
BCWorld Pharm. Co. Ltd.
|
Korea
|
-
|
08 October 2021
|
29 June 2025
|
| View |
|
DRP-4542-02
|
Clarithromycin
|
None
|
500 mjg
|
Film Coated Tablet
|
Antibacterial (Macrolide)
|
Medico Remedies Limited
|
India
|
Automatic Renewal
|
29 May 2023
|
26 July 2028
|
| View |
|
DRP-7543-02
|
CEFUROXIME (AS AXETIL)
|
UTIROX
|
250 mg/5 mL
|
Granules For Oral Suspension
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
14 June 2024
|
14 October 2029
|
| View |
|
DRP-6687-01
|
Sterile Water For Injection
|
None
|
NA
|
Solution For Diluent Use Only
|
-
|
Samrudh Pharmaceutical Pvt. Ltd.
|
India
|
-
|
13 October 2021
|
19 May 2026
|
| View |
|
DRP-10556
|
Clobetasol Propionate
|
Clobesaph
|
500 mcg/g (0.05% w/w)
|
Cream
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
-
|
15 October 2021
|
15 October 2026
|
| View |
|
DRP-10555
|
Hydrocortisone
|
Saphcortisone
|
10 mg/g (1% w/w)
|
Cream
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial (Correction)
|
28 October 2022
|
15 October 2026
|
| View |
|
DRP-1182-03
|
Cetirizine Dihydrochloride
|
Cetiron
|
10 mg
|
Tablet
|
H1-Receptor Antagonist (Antihistamine)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
04 August 2023
|
16 December 2028
|
| View |
|
DRP-10545
|
Cefalexin
|
None
|
500mg
|
Capsule
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
-
|
14 October 2021
|
18 May 2025
|